--- title: "Radium-223 therapy for bone metastasis from prostate cancer" ocid: "ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a.json" source: "Contracts Finder" current_stage: "Award" buyer: "NORTHAMPTON GENERAL HOSPITAL N H S TRUST" published: "2016-12-22" --- # Radium-223 therapy for bone metastasis from prostate cancer Buyer: NORTHAMPTON GENERAL HOSPITAL N H S TRUST Current stage: Award OCID: ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a.json) ## Summary The Northampton General Hospital NHS Trust is currently involved in a public procurement process to acquire Radium-223 therapy for treating bone metastasis from prostate cancer. This tender, classified under health and social work services, was published on 28 November 2016, with the tender period ending on 3 December 2016. The contract, valued at £1,500,000, is set to commence on 5 December 2016 and will run until 21 December 2020. The procurement was initiated through an accelerated restricted procedure, highlighting the urgency of the treatment needed in the East Midlands region of the United Kingdom. This procurement presents significant opportunities for businesses in the pharmaceutical and healthcare sectors, especially for small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) that provide innovative medical therapies. Companies with expertise in radiopharmaceuticals or those that can meet the specific regulatory and health standards required for this treatment would be particularly well-suited to compete. Engaging in this contract could further enhance a business's footprint in the healthcare market, particularly in delivering critical treatments that directly impact patient care outcomes. ## Notice NGHT has had to publish a VEAT notice for the following therapy: Xofigo (Radium 223) Dose. The reason for the VEAT notice was due to: "There was a palliative treatment called Strontium that could be used for bone pain, however this involved some significant side-effects and hence it has not been used for a number of years. This new treatment (Radium 223) has been shown to significantly improve overall survival for this group of patients. (ALSYMPCA trial). Currently these patients are either sent elsewhere for the same treatment, or they do not receive treatment. This is the only radiopharmaceutical that has been granted NICE approval for treatment of bone metastasis, and is the only Radium (223) product currently available commercially. ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/c5870a3f-91ee-4056-b444-6ea461521a27 | | Notice type | Award Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Selective | | Procurement method details | Other - | | Tender suitability | SME, VCSE | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 22 Dec 2016 | | Submission deadline | 3 Dec 2016 | | Future notice date | Not specified | | Award date | 24 Nov 2016 | | Contract period | 22 Dec 2016 - 3 Sep 2020 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,500,000 | | Lots value | Not specified | | Awards value | £2,200,000 | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Not specified | | Awards status | Active | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NORTHAMPTON GENERAL HOSPITAL N H S TRUST | | Locality | NORTHAMPTON | | Post town | Northampton | | Postcode | NN1 5BD | | Country | England | | ITL 1 | TLF East Midlands (England) | | ITL 2 | TLF2 Leicestershire, Rutland and Northamptonshire | | ITL 3 | TLF24 West Northamptonshire | | Local authority | West Northamptonshire | | Electoral ward | Delapre and Rushmere | | Westminster constituency | Northampton South | | Delivery location | TLF East Midlands (England) | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | BAYER | ## CPV Codes ### Divisions - 85 - Health and social work services ### Codes - 85000000 - Health and social work services ## Release History - 22 Dec 2016 at 14:20 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/c5870a3f-91ee-4056-b444-6ea461521a27 - 28 Nov 2016 at 09:32 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/6304c99e-0fd4-4530-8d47-cd8e8f19a70d ## Documents - https://www.contractsfinder.service.gov.uk/Notice/c5870a3f-91ee-4056-b444-6ea461521a27 22nd December 2016 - Awarded contract notice on Contracts Finder - https://www.contractsfinder.service.gov.uk/Notice/6304c99e-0fd4-4530-8d47-cd8e8f19a70d 28th November 2016 - Opportunity notice on Contracts Finder ## Notice URLs - http://www.northamptongeneral.nhs.uk/Home.aspx ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-06fa79dc-259f-4c60-9146-15668762fd7a.json.